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Endogeneity in
Logistic
Regression Models 
To the Editor: Ethelberg et al. (1)
report on a study of the determinants
of hemolytic uremic syndrome result-
ing from Shiga toxin–producing
Escherichia coli. The dataset is rela-
tively small, and the authors use step-
wise logistic regression models to
detect small differences. This indi-
cates that the authors were aware of
the limitations of the statistical power
of the study. Despite this, the study
has an analytic flaw that seriously
reduces the statistical power of the
study.
An often overlooked problem in
building statistical models is that of
endogeneity, a term arising from
econometric analysis, in which the
value of one independent variable is
dependent on the value of other pre-
dictor variables. Because of this endo-
geneity, significant correlation can
exist between the unobserved factors
contributing to both the endogenous
independent variable and the depend-
ent variable, which results in biased
estimators (incorrect regression coef-
ficients) (2). Additionally, the correla-
tion between the dependent variables
can create significant multicollineari-
ty, which violates the assumptions of
standard regression models and
results in inefficient estimators. This
problem is shown by model-generated
coefficient standard errors that are
larger than true standard errors, which
biases the interpretation towards the
null hypothesis and increases the like-
lihood of a type II error. As a result,
the power of the test of significance
for an independent variable X1 is
reduced by a factor of (1-r2
(1|2,3,….)),
where r(1|2,3,….) is defined as the multi-
ple correlation coefficient for the
model X1 = f(X2,X3,…), and all Xi are
independent variables in the larger
model (3,4).
The results of this study clearly
show that the presence of bloody diar-
rhea is an endogenous variable in the
model showing predictors of hemolyt-
ic uremic syndrome, in that the diar-
rhea is shown to be predicted by, and
therefore strongly correlated with,
several other variables used to predict
hemolytic uremic syndrome.
Similarly, Shiga toxin 1 and 2 (stx1,
stx2)  genes are expected to be key
predictors of the presence of bloody
diarrhea, independent of strain, due to
the known biochemical effects of that
toxin (5,6). Because the strain is in
part determined by the presence of
these toxins, including both strain and
genotype in the model means that the
standard errors for variables for the
Shiga-containing strains and bloody
diarrhea symptom are likely to be too
high, and hence the significance lev-
els (p values) obtained from the
regression models are higher than the
true probability because of a type I
error. 
This flaw is a particular problem
with studies that use a conditional
stepwise technique for including or
excluding variables. The authors note
that they excluded variables from the
final model if the significance in ini-
tial models for those variables was
less than an α level (p value) of 0.05.
Given the inefficiencies due to the
endogeneity of bloody diarrhea, as
well as those that may result from
other collinearities significant predic-
tors were likely excluded from the
study, although this cannot be con-
firmed from the data presented. 
The problems associated with the
endogeneity of bloody diarrhea can be
overcome by a number of approaches.LETTERS
For example, the simultaneous equa-
tions approach, such as that outlined
by Greene (7), would have used pre-
dicted values of bloody diarrhea from
the first stage of the model as instru-
mental variables for the actual value
in the model for hemolytic uremic
syndrome. Structural equations
approaches, such as those suggested
by Greenland (8), would also be
appropriate. However, bloody diar-
rhea is not the only endogenous vari-
able in their models, and extensive
modeling would be necessary to iso-
late the independent effects of the var-
ious predictor variables. Given the
small sample size, this may not be
possible.
The underlying problem in the
study is the theoretical specifications
for the model, in which genotypes,
strains, and symptoms are mixed,
despite reasonable expectations that
differences in 1 level may predict dif-
ferences in another. For example, the
authors’ data demonstrate that all
O157 strains contain the stx2 gene and
have higher rates of causing hemolyt-
ic uremic syndrome and bloody
diarrhea. This calls into question the
decision to build an analytic model
combining 3 distinct levels of analy-
sis. Such a model depends on the
independence of the variables to gain
unbiased, efficient estimators. The
model of the relationships one would
develop from a theoretical perspective
would predict the opposite (Figure).
We expect that the genotypes (by def-
inition) will predict the strain, and that
strains have a differential effect on
symptoms. The high level of inter-
variable correlation due to these rela-
tionships, coupled with the decision to
exclude variables based on likely
inefficient p values, raises questions
concerning the reliability of the
results and conclusions. In particular,
the conclusions that strains O157 and
O111 are not predictors of hemolytic
uremic syndrome deserve to be revis-
ited; other excluded variables may
also be significant predictors when
considered under an appropriate
model. These problems point to the
need to ensure proper specification of
analytic models and to demonstrate
due regard for the underlying assump-
tions of statistical models used. 
George Avery*
*University of Minnesota, Duluth,
Minnesota, USA
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In response: We appreciate
Avery’s interest (1) in our article (2),
although we believe the critique of the
methods is largely based on misunder-
standings. We developed a model for
the risk of progression to hemolytic
uremic syndrome (HUS) containing 3
variables: whether the infecting Shiga
toxin–producing Escherichia coli iso-
late had the stx2 gene, age of the
patient, and occurrence of bloody diar-
rhea. The critique relates to the fact
that bloody diarrhea and stx2 are not
independent, since we showed that
stx2 was strongly associated with pro-
gression to HUS (odds ratio [OR] =
504 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 3, March 2005
Figure. Model for determining virulence factors for hemolytic uremic syndromeLETTERS
18.9) and also weakly associated with
development of bloody diarrhea (OR
= 2.5) (2). Avery uses the term endo-
geneity as it is used in econometric
analyses; however, the term “interme-
diary variable,” i.e., a factor in the
causal pathway leading from exposure
to disease, is more frequently used in
epidemiology. In this context, we
chose to consider bloody diarrhea as a
potential confounder (3). A con-
founder is a risk factor but is also inde-
pendently associated with the expo-
sure variable of interest and is not
regarded as part of the causal pathway
(see online Figure at http://www.cdc.
gov/ ncidod/EID/vol 11no03/05-0071-
G.htm). Bloody diarrhea may act as a
confounder if patients with bloody
stools are treated differently by the
examining physicians or if, for
instance, unknown virulence factors
contribute to the risk of having bloody
stools.
A second line of critique of our
methods apparently develops from the
idea that virulence factors determine
the serogroup. This idea, however, is a
biological misconception. In fact, vir-
ulence genes and serogroup are inde-
pendent at the genetic level, and an
important point of our article is that
HUS is determined by the virulence
gene composition of the strain rather
than the serogroup.
Regardless of the status of the
bloody diarrhea variable, excluding it
from the model doesn’t change the
conclusions of the article. A revised
model contains only the significant
variables age and stx2 (Table).
Serotype O157 is still not an inde-
pendent predictor of HUS, and this
result is robust. 
Steen Ethelberg* and Kåre Mølbak*
*Statens Serum Institut, Copenhagen,
Denmark
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Rectal
Lymphogranuloma
Venereum, France 
To the Editor: Lymphogranuloma
venereum (LGV), a sexually transmit-
ted disease (STD) caused by
Chlamydia trachomatis serovars L1,
L2, or L3, is prevalent in tropical
areas but occurs sporadically in the
western world, where most cases are
imported (1). LVG commonly causes
inflammation and swelling of the
inguinal lymph nodes, but it can also
involve the rectum and cause acute
proctitis, particularly among men who
have sex with men. However, LGV
serovars of C. trachomatis remain a
rare cause of acute proctitis, which is
most frequently caused by Neisseria
gonorrhoeae or by non-LGV C. tra-
chomatis (2). In 1981, in a group of 96
men who have sex with men with
symptoms suggestive of proctitis in
the United States, Quinn et al. found
that 3 of 14 C. trachomatis infections
were caused by LGV serovar L2 (3).
In France, 2 cases of rectal LGV were
reported in an STD clinic in Paris
from 1981 to 1986 (4). In 2003, an
outbreak of 15 rectal LGV cases was
reported among men who have sex
with men in Rotterdam; 13 were HIV-
infected, and all reported unprotected
sex in neighboring countries, includ-
ing Belgium, France, and the United
Kingdom (5). At the same time, a rise
in C. trachomatis proctitis (diagnosed
by using polymerase chain reaction
[PCR]; [Cobas Amplicor Roche
Diagnostic System, Meylan, France])
was detected in 3 laboratories in Paris
and in the C. trachomatis national ref-
erence center located in Bordeaux. To
identify the serovars of these C. tra-
chomatis spp., all stored rectal speci-
mens were analyzed by using a nested
omp1 PCR-restriction fragment
length polymorphism assay. The
amplified DNA product was digested
by restriction enzymes. Analysis of
digested DNAwas performed by elec-
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